Clinical Trial Update: Premarket Clinical Safety Assessment of the ELISIO™-HX [NA]

View source ↗

Summary

Premarket safety assessment for ELISIO™-HX has been completed in a clinical trial sponsored by Nipro Medical Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Diseases
• End-stage Renal Disease
• Renal Failure

Drugs mentioned

• ELISIO™-HX

Snippet

Sponsor: Nipro Medical Corporation | Conditions: Renal Failure, Acute Renal Failure | NA | Status: COMPLETED